Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 77-80 , 15 May 2010

Acetazolamide improves cerebral hemodynamics in CADASIL

Received 16 June 2009 ,Revised 21 January 2010 ,Accepted 27 January 2010.

References 

  1. Frankel H, Garcia E, Malik F, Weiss J, Weiss H. Effect of acetazolamide on cerebral blood flow and capillary patency. J Appl Physiol. 1992;73:1756–1761
  2. Vagal AS, Leach JL, Fernandez-Ulloa M, Zuccarello M. The acetazolamide challenge: techniques and applications in the evaluation of chronic cerebral ischemia. Am J Neuroradiol. 2009;30:876–884
  3. Settakis G, Molnar C, Kerenyi L, Kollar J, Legemate D, Csiba L, et al. Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature. Eur J Neurol. 2003;10:609–620
  4. Gambhir S, Inao S, Tadokoro M, Nishino M, Ito K, Ishigaki T, et al. Comparison of vasodilatory effect of carbon dioxide inhalation and intravenous acetazolamide on brain vasculature using positron emission tomography. Neurol Res. 1997;19:139–144
  5. Brian JE. Carbon dioxide and the cerebral circulation. Anesthesiology. 1998;88:1365–1386
  6. White RP, Deane C, Vallance P, Markus HS. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke. 1998;29:467–472
  7. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet. 1993;3:256–259
  8. Guidetti D, Casali B, Mazzei RL, Dotti MT. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Clin Exp Hypertens. 2006;28:271–277
  9. Chabriat H, Levy C, Taillia H, Iba ZM, Vahedi K, Joutel A, et al. Patterns of MRI lesions in CADASIL. Neurology. 1998;51:452–457
  10. Kalaria RN, Viitanen M, Kalimo H, Dichgans M, Tabira T. The pathogenesis of CADASIL: an update. J Neurol Sci. 2004;226(1–2):35–39
  11. Pfefferkorn T, von Stuckrad-Barre S, Herzog J, Gasser T, Hamann GF, Dichgans M. Reduced cerebrovascular CO2 reactivity in CADASIL: a transcranial Doppler sonography study. Stroke. 2001;32:17–21
  12. Hussain MB, Singhal S, Markus HS, Singer DR. Abnormal vasoconstrictor responses to angiotensin II and noradrenaline in isolated small arteries from patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Stroke. 2004;35:853–858
  13. Gobron C., Vahedi K., Vicaut E., Stucker O., Laemmel E., Baudry N., et al. Characteristic features of in vivo skin microvascular reactivity in CADASIL. 2007;27:250–257.
  14. Dubroca C, Lacombe P, Domenga V, Maciazek J, Levy B, Tournier-Lasserve E, et al. Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke. 2005;36:113–117
  15. Lacombe P, Oligo C, Domenga V, Tournier-Lasserve E, Joutel A. Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke. 2005;36:1053–1058
  16. van den Boom R, Lesnik Oberstein SA, Spilt A, Behloul F, Ferrari MD, Haan J, et al. Cerebral hemodynamics and white matter hyperintensities in CADASIL. J Cereb Blood Flow Metab. 2003;23:599–604
  17. Chabriat H, Pappata S, Ostergaard L, Clark CA, Pachot-Clouard M, Vahedi K, et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke. 2000;31:1904–1912
  18. Tuominen S, Miao Q, Kurki T, Tuisku S, Poyhonen M, Kalimo H, et al. Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients. Stroke. 2004;35:1063–1067
  19. Pfefferkorn T, von Stuckrad-Barre S, Herzog J, Gasser T, Hamann GF, Dichgans M. Reduced cerebrovascular CO2 reactivity in CADASIL: a transcranial Doppler sonography study. Stroke. 2001;32:17–21
  20. Singhal S, Markus HS. Cerebrovascular reactivity and dynamic autoregulation in nondemented patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). J Neurol. 2005;252:163–167
  21. Forteza AM, Brozman B, Rabinstein AA, Romano JG, Bradley WG. Acetazolamide for the treatment of migraine with aura in CADASIL. Neurology. 2001;57:2144–2145
  22. Weller M, Dichgans J, Klockgether T. Acetazolamide-responsive migraine in CADASIL. Neurology. 1998;50:1505
  23. Chimowitz MI, Furlan AJ, Jones SC, Sila CA, Lorig RL, Paranandi L, et al. Transcranial Doppler assessment of cerebral perfusion reserve in patients with carotid occlusive disease and no evidence of cerebral infarction. Neurology. 1993;43:353–357
  24. Silvestrini M, Troisi E, Matteis M, Cupini LM, Caltagirone C. Transcranial Doppler assessment of cerebrovascular reactivity in symptomatic and asymptomatic severe carotid stenosis. Stroke. 1996;27:1970–1973
  25. Muller M, Voges M, Piepgras U, Schimrigk K. Assessment of cerebral vasomotor reactivity by Transcranial Doppler utrasound and breathholding. A comparison with acetazolamide as vasodilatory stimulus. Stroke. 1995;26:96–100
  26. Aalkjaer C, Poston L. Effects of pH on vascular tension: which are the important mechanisms?. J Vasc Res. 1996;33:347–359
  27. Heuser D, Astrup J, Lassen NA, Betz BE. Brain carbonic acid acidosis after acetazolamide. Acta Physiol Scand. 1975;93:385–390
  28. Dubroca C, Lacombe P, Domenga V, Maciazek J, Levy B, Tournier-Lasserve E, et al. Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke. 2005;36:113–117

PII: S0022-510X(10)00053-5

doi: 10.1016/j.jns.2010.01.023

Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 77-80 , 15 May 2010

Article Tools

* Image Usage & Resolution